Cresset Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.1M | Buy |
271,475
+7,930
| +3% | +$928K | 0.13% | 110 |
|
|
2026
Q1 | $31.9M | Buy |
263,545
+17,397
| +7% | +$2.01M | 0.14% | 101 |
|
|
2025
Q4 | $26.1M | Buy |
246,148
+2,143
| +0.9% | +$201K | 0.11% | 112 |
|
|
2025
Q3 | $20.7M | Buy |
244,005
+7,062
| +3% | +$582K | 0.09% | 133 |
|
|
2025
Q2 | $18.9M | Sell |
236,943
-62,684
| -21% | -$4.98M | 0.09% | 132 |
|
|
2025
Q1 | $27.1M | Sell |
299,627
-1,539
| -0.5% | -$144K | 0.14% | 103 |
|
|
2024
Q4 | $30.2M | Sell |
301,166
-139,386
| -32% | -$14.4M | 0.14% | 95 |
|
|
2024
Q3 | $50.3M | Sell |
440,552
-14,969
| -3% | -$1.78M | 0.19% | 77 |
|
|
2024
Q2 | $56.7M | Buy |
455,521
+48,796
| +12% | +$6.29M | 0.24% | 63 |
|
|
2024
Q1 | $54M | Buy |
406,725
+40,134
| +11% | +$4.95M | 0.26% | 54 |
|
|
2023
Q4 | $40.2M | Sell |
366,591
-906
| -0.2% | -$94K | 0.24% | 61 |
|
|
2023
Q3 | $38.1M | Buy |
367,497
+9,268
| +3% | +$999K | 0.15% | 76 |
|
|
2023
Q2 | $41.6M | Buy |
358,229
+263,179
| +277% | +$29.9M | 0.05% | 115 |
|
|
2023
Q1 | $10.2M | Sell |
95,050
-104,106
| -52% | -$11.2M | 0.2% | 75 |
|
|
2022
Q4 | $19.2M | Sell |
199,156
-8,368
| -4% | -$855K | 0.24% | 54 |
|
|
2022
Q3 | $18M | Sell |
207,524
-2,006
| -1% | -$179K | 0.23% | 49 |
|
|
2022
Q2 | $19.1M | Buy |
209,530
+2,123
| +1% | +$188K | 0.23% | 47 |
|
|
2022
Q1 | $17.1M | Sell |
207,407
-2,963
| -1% | -$234K | 0.18% | 57 |
|
|
2021
Q4 | $16.3M | Buy |
210,370
+7,823
| +4% | +$623K | 0.16% | 65 |
|
|
2021
Q3 | $15.3M | Buy |
202,547
+2,703
| +1% | +$206K | 0.21% | 44 |
|
|
2021
Q2 | $15.7M | Sell |
199,844
-1,016
| -0.5% | -$75.6K | 0.22% | 42 |
|
|
2021
Q1 | $14.9M | Buy |
200,860
+932
| +0.5% | +$68.7K | 0.24% | 40 |
|
|
2020
Q4 | $15.7M | Sell |
199,928
-31,452
| -14% | -$2.41M | 0.26% | 37 |
|
|
2020
Q3 | $18.4M | Buy |
231,380
+3,070
| +1% | +$240K | 0.34% | 29 |
|
|
2020
Q2 | $17M | Buy |
228,310
+36,776
| +19% | +$2.77M | 0.37% | 28 |
|
|
2020
Q1 | $14.2M | Buy |
191,534
+15,953
| +9% | +$1.25M | 0.43% | 29 |
|
|
2019
Q4 | $15.3M | Buy |
175,581
+5,850
| +3% | +$480K | 0.42% | 26 |
|
|
2019
Q3 | $13.7M | Buy |
169,731
+10,502
| +7% | +$842K | 0.42% | 30 |
|
|
2019
Q2 | $12.8M | Buy |
159,229
+9,228
| +6% | +$707K | 0.4% | 36 |
|
|
2019
Q1 | $12M | Buy |
150,001
+42,936
| +40% | +$3.21M | 0.46% | 22 |
|
|
2018
Q4 | $7.86M | Buy |
+107,065
| New | +$7.56M | 0.47% | 23 |
|
Other funds holding MRK
Cresset Asset Management's MRK Position: Q2 2026 in Review
Cresset Asset Management increased its Merck (MRK) stake by 3% in Q2 2026, buying an estimated $928K and bringing the position to 271,475 shares worth $35.1M. The position accounts for 0.13% of the portfolio, ranked #110.
Cresset Asset Management first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $56.7M in Q2 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cresset Asset Management held 271,475 shares of Merck worth $35.1M as of Q2 2026.
- Cresset Asset Management bought 7,930 Merck shares in Q2 2026, an estimated $928K.
- Merck made up 0.13% of Cresset Asset Management's portfolio in Q2 2026, its #110 holding.
- Cresset Asset Management first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's Merck position peaked at $56.7M in Q2 2024.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.